Literature DB >> 2125734

Self-administration in baboons and the discriminative stimulus effects in rats of bupropion, nomifensine, diclofensine and imipramine.

R J Lamb1, R R Griffiths.   

Abstract

The behavioral effects of the antidepressants nomifensine, diclofensine, bupropion, and imipramine were examined using a cocaine substitution drug self-administration procedure in baboons and a cocaine drug discrimination procedure in rats. Intravenous self-administration of the antidepressants was examined in baboons under conditions in which baseline responding was maintained by intravenous injections of cocaine HCl (0.32 mg/kg/injection). Drug was available under a fixed-ratio 80-response or 160-response schedule of intravenous injection. Each drug injection was followed by a 3-h time-out allowing a maximum of eight injections per day. The antidepressants or their vehicles were substituted for cocaine for a period of 15 days, followed by a return to the cocaine baseline. Nomifensine, diclofensine and bupropion all maintained self-administration behavior at levels above those maintained by their respective vehicles. Some doses of nomifensine, diclofensine, and bupropion maintained levels of behavior similar to those maintained under baseline cocaine conditions. High doses of imipramine maintained levels of behavior above those maintained by its vehicle, but the amount of behavior maintained under these conditions was extremely small. In a second experiment rats were trained to discriminate 32 mumol/kg cocaine (IP 10 min presession) from no drug in a two-lever food reinforced drug discrimination procedure in which responding on one lever was reinforced following ten consecutive responses when the session was preceded by cocaine administration, while responding on the other lever was similarly reinforced in the absence of cocaine pretreatment. Cocaine, nomifensine, diclofensine, and bupropion all dose-dependently occasioned cocaine-appropriate responding. Imipramine did not occasion cocaine-appropriate responding over a range of behaviorally active doses.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2125734     DOI: 10.1007/bf02245920

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  36 in total

1.  Bupropion hydrochloride ((+/-) alpha-t-butylamino-3-chloropropiophenone HCl): a novel antidepressant agent.

Authors:  F E Soroko; N B Mehta; R A Maxwell; R M Ferris; D H Schroeder
Journal:  J Pharm Pharmacol       Date:  1977-12       Impact factor: 3.765

2.  Cocaine receptors on dopamine transporters are related to self-administration of cocaine.

Authors:  M C Ritz; R J Lamb; S R Goldberg; M J Kuhar
Journal:  Science       Date:  1987-09-04       Impact factor: 47.728

3.  Discriminative stimulus properties of cocaine: neuropharmacological characteristics as derived from stimulus generalization experiments.

Authors:  F C Colpaert; C J Niemegeers; P A Janssen
Journal:  Pharmacol Biochem Behav       Date:  1979-04       Impact factor: 3.533

4.  Addiction to secobarbital and chlordiazepoxide in the rhesus monkey by means of a self-infusion preference procedure.

Authors:  J D Findley; W W Robinson; L Peregrino
Journal:  Psychopharmacologia       Date:  1972

5.  Comparison of fixed-ratio and progressive-ratio schedules of maintenance of stimulant drug-reinforced responding.

Authors:  G Winger; J H Woods
Journal:  Drug Alcohol Depend       Date:  1985-05       Impact factor: 4.492

6.  Pharmacological and biochemical studies with three metabolites of nomifensine.

Authors:  H Kruse; I Hoffmann; H J Gerhards; M Leven; U Schacht
Journal:  Psychopharmacology (Berl)       Date:  1977-01-31       Impact factor: 4.530

7.  Lorazepam and pentobarbital discrimination: interactions with CGS 8216 and caffeine.

Authors:  N A Ator; R R Griffiths
Journal:  Eur J Pharmacol       Date:  1985-01-02       Impact factor: 4.432

8.  Comparison of behavior maintained by infusions of eight phenylethylamines in baboons.

Authors:  R R Griffiths; G Winger; J V Brady; J D Snell
Journal:  Psychopharmacology (Berl)       Date:  1976-11-24       Impact factor: 4.530

9.  Effects of dopamine uptake inhibitors on schedule-controlled behavior in the squirrel monkey.

Authors:  J W McKearney
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

10.  Sodium-sensitive cocaine binding to rat striatal membrane: possible relationship to dopamine uptake sites.

Authors:  L T Kennedy; I Hanbauer
Journal:  J Neurochem       Date:  1983-07       Impact factor: 5.372

View more
  22 in total

Review 1.  Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent.

Authors:  Linda P Dwoskin; Anthony S Rauhut; Kelley A King-Pospisil; Michael T Bardo
Journal:  CNS Drug Rev       Date:  2006 Fall-Winter

2.  Psychostimulant-like discriminative stimulus and locomotor sensitization properties of the wake-promoting agent modafinil in rodents.

Authors:  Neil E Paterson; Allison Fedolak; Berend Olivier; Taleen Hanania; Afshin Ghavami; Barbara Caldarone
Journal:  Pharmacol Biochem Behav       Date:  2010-03-25       Impact factor: 3.533

3.  Nicotinic acetylcholine receptor efficacy and pharmacological properties of 3-(substituted phenyl)-2β-substituted tropanes.

Authors:  F Ivy Carroll; Bruce E Blough; S Wayne Mascarella; Hernán A Navarro; J Brek Eaton; Ronald J Lukas; M Imad Damaj
Journal:  J Med Chem       Date:  2010-11-08       Impact factor: 7.446

Review 4.  Bupropion: a review of its use in the management of smoking cessation.

Authors:  K J Holm; C M Spencer
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

5.  [Intravenous abuse of bupropione].

Authors:  N Behler; A Lehmann; B Malchow; U Palm
Journal:  Nervenarzt       Date:  2017-11       Impact factor: 1.214

6.  Evaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil.

Authors:  L H Gold; R L Balster
Journal:  Psychopharmacology (Berl)       Date:  1996-08       Impact factor: 4.530

7.  Psychological and physiological effects of bupropion compared to methylphenidate after prolonged administration in healthy volunteers (NCT00285155).

Authors:  Hugues Chevassus; Anne Farret; Jean-Pierre Gagnol; Claire-Anne Ponçon; Françoise Costa; Clarisse Roux; Florence Galtier; Pierre Petit
Journal:  Eur J Clin Pharmacol       Date:  2012-10-09       Impact factor: 2.953

8.  Pavlovian drug discrimination with bupropion as a feature positive occasion setter: substitution by methamphetamine and nicotine, but not cocaine.

Authors:  Jamie L Wilkinson; Chia Li; Rick A Bevins
Journal:  Addict Biol       Date:  2008-12-12       Impact factor: 4.280

9.  Preclinical evaluation of the abuse potential of the analgesic bicifadine.

Authors:  Katherine L Nicholson; Robert L Balster; Krystyna Golembiowska; Magdalena Kowalska; Joseph P Tizzano; Phil Skolnick; Anthony S Basile
Journal:  J Pharmacol Exp Ther       Date:  2009-04-08       Impact factor: 4.030

10.  Changes in food reward following smoking cessation: a pharmacogenetic investigation.

Authors:  Caryn Lerman; Wade Berrettini; Angela Pinto; Freda Patterson; Susan Crystal-Mansour; E Paul Wileyto; Stephanie L Restine; Debra G B Leonard; Peter G Shields; Leonard H Epstein
Journal:  Psychopharmacology (Berl)       Date:  2004-04-27       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.